The Ubiquitination-Dependent and -Independent Functions of Cereblon in Cancer and Neurological Diseases.

Author: XuGuoqiang, ZhouLiang

Paper Details 
Original Abstract of the Article :
Cereblon (CRBN) mediates the teratogenic effect of thalidomide in zebrafish, chickens, and humans. It additionally modulates the anti-myeloma effect of the immunomodulatory drugs (IMiDs) thalidomide, lenalidomide, and pomalidomide. IMiDs bind to CRBN and recruit neo-substrates for their ubiquitinati...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1016/j.jmb.2022.167457

データ提供:米国国立医学図書館(NLM)

Cereblon: A Multifaceted Player in Cancer and Neurological Diseases

This research, like a camel caravan venturing deep into the desert, delves into the multifaceted world of Cereblon (CRBN), a protein involved in various cellular processes. The study focuses on the ubiquitination-dependent and -independent functions of CRBN, exploring its role in cancer and neurological diseases. The authors highlight the teratogenic effect of thalidomide and the anti-myeloma effect of immunomodulatory drugs (IMiDs) that bind to CRBN. They discuss the potential of CRBN as a target for drug discovery, particularly in the context of proteolysis-targeting chimeras (PROTACs). This research provides a comprehensive overview of CRBN's functions and its potential as a therapeutic target.

Cereblon: A Key Player in Cellular Regulation

This research, like a desert explorer uncovering hidden oases, reveals the multifaceted nature of Cereblon (CRBN). The authors' findings highlight the critical role of CRBN in regulating various cellular processes, including protein degradation and signaling pathways. This knowledge is essential for understanding the mechanisms of disease and developing targeted therapies.

CRBN: A Potential Target for Drug Discovery

The study's findings suggest that CRBN could be a promising target for drug discovery, particularly in the context of cancer and neurological diseases. By understanding the interactions between CRBN and its ligands, researchers may be able to develop new drugs that target this protein and modulate its functions. This approach, like finding a hidden water source in the desert, holds the potential for significant therapeutic breakthroughs.

Dr.Camel's Conclusion

This research, like a desert oasis offering hope and renewal, explores the potential of Cereblon (CRBN) as a target for drug discovery. The authors' findings provide a comprehensive overview of CRBN's diverse functions, highlighting its potential as a therapeutic target for a range of diseases. This research, like a caravan crossing a vast and challenging landscape, offers valuable insights into the complex world of cellular regulation and drug discovery.

Date :
  1. Date Completed 2022-05-09
  2. Date Revised 2022-05-31
Further Info :

Pubmed ID

35045330

DOI: Digital Object Identifier

10.1016/j.jmb.2022.167457

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.